Professor of Medicine, Cedars-Sinai Medical Center
Pulmonology
Dr. Victor F. Tapson, MD
|
|
Give Review
Victor F. Tapson, MD works in the field of Pulmonology. He went to Drexel University College of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Victor Tapson is also a published doctor. He has 57 paper published. The most recent paper is: Multidetector computed tomographic pulmonary angiography in patients with a high clinical probability of pulmonary embolism. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Multidetector computed tomographic Pulmonary angiography in patients with a high clinical probability of Pulmonary embolism.
- Long-term safety and efficacy of imatinib in Pulmonary arterial hypertension.
- Comprehensive Assessment of Right Ventricular Function in Patients with Pulmonary Hypertension with Global Longitudinal Peak Systolic Strain Derived from Multiple Righ...
- Two formulations of epoprostenol sodium in the treatment of Pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in Pulmonary arterial hypertension),...
- Lung transplantation and atrial septostomy in Pulmonary arterial hypertension.
- Treatment goals of Pulmonary hypertension.
- Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients. Subgroup analysis from the EXCLAIM randomised trial.
- One-year experience with intravenous treprostinil for Pulmonary arterial hypertension.
- Contemporary trends in the diagnosis and management of Pulmonary arterial hypertension: an initiative to close the care gap.
- Rapid transition from inhaled iloprost to inhaled treprostinil in patients with Pulmonary arterial hypertension.
- Incidence of thrombocytopenia among patients receiving heparin venous thromboEmbolism prophylaxis.
- Oral treprostinil for the treatment of Pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibit...
- Long-term effects of inhaled treprostinil in patients with Pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arte...
- Treatment of Pulmonary embolism: anticoagulation, thrombolytic therapy, and complications of therapy.
- Commentary: Persistent Gaps in VTE Prophylaxis in Orthopedic Surgery: Will New Educational Strategies Help?
- Crew Resource Management and VTE Prophylaxis in Surgery: A Quality Improvement Initiative.
- Acute Pulmonary embolism: comment on "time trends in Pulmonary embolism in the United States".
- Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for Pulmonary embolism in PIOPED III.
- Signal quality of single dose gadobenate dimeglumine Pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimeglumine.
- Interventional therapies for venous thromboEmbolism: vena caval interruption, surgical embolectomy, and catheter-directed interventions.
- Addition of inhaled treprostinil to oral therapy for Pulmonary arterial hypertension: a randomized controlled clinical trial.
- SPECT in acute Pulmonary embolism.
- D-dimers and efficacy of clinical risk estimation algorithms: sensitivity in evaluation of acute Pulmonary embolism.
- End points and clinical trial design in Pulmonary arterial hypertension.
- Updated evidence-based treatment algorithm in Pulmonary arterial hypertension.
- Thrombolytic therapy for acute Pulmonary embolism: a critical appraisal.
- Thrombolytic therapy for venous thromboEmbolism: current clinical practice.
- Diagnosis of Pulmonary embolism in the coronary care unit.
- Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III).
- Clinical probability and D-dimer testing: how should we use them in clinical practice?
- Deep venous thrombosis and Pulmonary thromboembolism: evolving concepts and controversies. Preface.
- Clinical characteristics of patients with acute Pulmonary embolism: data from PIOPED II.
- Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in Pulmonary arterial hypertension.
- Randomized study of adding inhaled iloprost to existing bosentan in Pulmonary arterial hypertension.
- Incidence and prevalence of Chronic thromboembolic pulmonary hypertension: from acute to Chronic pulmonary embolism.
- Safety and efficacy of IV treprostinil for Pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial.
- Transition from intravenous epoprostenol to intravenous treprostinil in Pulmonary hypertension.
- Development of a research agenda for endovascular treatment of venous thromboEmbolism: proceedings from a multidisciplinary consensus panel.
- A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in Pulmonary hypertension.
- The response to inhaled nitric oxide in patients with Pulmonary artery hypertension is not masked by baseline vasodilator use.
- Brain natriuretic peptide: diagnostic and therapeutic implications in Pulmonary arterial hypertension.
- Thrombosis during pregnancy and the postpartum period.
- The diagnosis of acute venous thromboEmbolism.
- The role of smoking in coagulation and thromboembolism in Chronic obstructive pulmonary disease.
- Cutaneous findings in patients with Pulmonary arterial hypertension receiving long-term epoprostenol therapy.
- End points and clinical trial designs in Pulmonary arterial hypertension: clinical and regulatory perspectives.
- Clinical practice. The evaluation of suspected Pulmonary embolism.
- Effects of the dual endothelin receptor antagonist bosentan in patients with Pulmonary arterial hypertension: a 1-year follow-up study.
- Diagnosing and managing acute Pulmonary embolism: role of cardiac troponins.
- The evolution and impact of the American College of Chest Physicians consensus statement on antithrombotic therapy.
- Venous thromboEmbolism in intensive care patients.
- Electrocardiography to define clinical status in primary Pulmonary hypertension and Pulmonary arterial hypertension secondary to collagen vascular disease.
- Severe erythroderma as a complication of continuous epoprostenol therapy.
- Massive Pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options.
- Protect your health in the air. Most people with Chronic health conditions can travel by air safely--if they take a few precautions.
- Outcome of Lung transplantation in patients with mycetomas.
Schools
Hahnemann Univ Sch Of Med
Duke University Med Center
Boston University Hospital
Procedures Preformed
- Bronchoscopy
- Continuous Positive Airway Pressure (CPAP)
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asthma
- Atelectasis
- View All
Doctors Specialties
- Pulmonology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Boston University Medical Center -
Duke University Hospital -
Drexel University College of Medicine
Hospital
-
Duke Raleigh Hospital -
Duke University Hospital -
Duke Regional Hospital -
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1275693400 | |
| NPPES Provider LastName | TAPSON | |
| NPPES Provider FirstName | VICTOR | |
| NPPES Provider ZIPCode | 277042121 | |
| NPPES Provider State | NC | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 1298.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275693400 |
| Last Name Of The Provider | TAPSON |
| First Name Of The Provider | VICTOR |
| View All |
Similar Doctors
|
|
Dr. Rahnana Sachs, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dani Hackner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy A. Falk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sidney A. Mercado, MD |
|
|
Dr. Babak B. Saedi, MD |
|
|
Dr. Vijay Babu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Balfe, MD
This Doctor is OpenDoctor Recommended.
|